Stanford Peng
2017
In 2017, Stanford Peng earned a total compensation of $546K as Executive Vice President of Research and Development and Chief Medical Officer at Nivalis Therapeutics, a 191% increase compared to previous year.
Compensation breakdown
| Option Awards | $171,010 |
|---|---|
| Salary | $375,000 |
| Total | $546,010 |
Peng received $375K in salary, accounting for 69% of the total pay in 2017.
Peng also received $171K in option awards.
Rankings
In 2017, Stanford Peng's compensation ranked 11,533rd out of 14,666 executives tracked by ExecPay. In other words, Peng earned more than 21.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,533 out of 14,666 | 21st |
Division Manufacturing | 4,524 out of 5,772 | 22nd |
Major group Chemicals And Allied Products | 1,653 out of 2,075 | 20th |
Industry group Drugs | 1,368 out of 1,731 | 21st |
Industry Pharmaceutical Preparations | 1,068 out of 1,333 | 20th |
Source: SEC filing on April 24, 2018.
Peng's colleagues
We found five more compensation records of executives who worked with Stanford Peng at Nivalis Therapeutics in 2017.
2017
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
2017
Janice Troha
Nivalis Therapeutics
Chief Operating Officer
2017
R Carruthers
Nivalis Therapeutics
Chief Financial Officer
2017
Jon Congleton
Nivalis Therapeutics
Chief Executive Officer
2017
Paul Rickey
Nivalis Therapeutics